|
|
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
Philippe Moreau
,
Cyrille Hulin
,
Aurore Perrot
,
Bertrand Arnulf
,
Karim Belhadj
,
et al.
Article dans une revue
hal-03604926v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Étude sur la perception des blessures par les athlètes et leurs influences sur la réalisation de mesures de prévention des blessures en athlétisme
M. Sorg
,
Alexis Ruffault
,
Simon Martin
,
C. Hanon
,
L. Jacquet
,
et al.
Article dans une revue
hal-03493869v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Philippe Moreau
,
Michel Attal
,
Cyrille Hulin
,
Bertrand Arnulf
,
Karim Belhadj
,
et al.
Article dans une revue
hal-03605015v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce?
Sophie Liabeuf
,
Karlijn J. van Stralen
,
Fergus Caskey
,
Francesca Tentori
,
Ronald L. Pisoni
,
et al.
Article dans une revue
hal-03578871v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|